127 related articles for article (PubMed ID: 3308589)
21. Cholecystokinin type A and type B receptor antagonists produce opposing effects on cholecystokinin-stimulated beta-endorphin secretion from the rat pituitary.
Millington WR; Mueller GP; Lavigne GJ
J Pharmacol Exp Ther; 1992 May; 261(2):454-61. PubMed ID: 1578360
[TBL] [Abstract][Full Text] [Related]
22. Effects of cholecystokinin and glucagon-like peptide 1 on the secretion of pancreatic polypeptide in mice.
Ahrén B; Gingerich RL; Havel PJ
Regul Pept; 1995 Nov; 59(3):297-302. PubMed ID: 8577934
[TBL] [Abstract][Full Text] [Related]
23. Physiological concentrations of cholecystokinin stimulate amino acid-induced insulin release in humans.
Rushakoff RJ; Goldfine ID; Carter JD; Liddle RA
J Clin Endocrinol Metab; 1987 Sep; 65(3):395-401. PubMed ID: 3305550
[TBL] [Abstract][Full Text] [Related]
24. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
Dourish CT; Rycroft W; Iversen SD
Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
[TBL] [Abstract][Full Text] [Related]
25. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718, on gastric emptying in the rat.
Decktor DL; Pendleton RG; Elnitsky AT; Jenkins AM; McDowell AP
Eur J Pharmacol; 1988 Mar; 147(2):313-6. PubMed ID: 3366182
[TBL] [Abstract][Full Text] [Related]
26. Asperlicin antagonizes stimulatory effects of cholecystokinin on isolated islets.
Zawalich WS; Diaz VA
Am J Physiol; 1987 Mar; 252(3 Pt 1):E370-4. PubMed ID: 3548432
[TBL] [Abstract][Full Text] [Related]
27. Synergistic impact of cholecystokinin and gastric inhibitory polypeptide on the regulation of insulin secretion.
Zawalich WS
Metabolism; 1988 Aug; 37(8):778-81. PubMed ID: 2841557
[TBL] [Abstract][Full Text] [Related]
28. Cholecystokinin receptors and vagal nerves in control of food intake in rats.
Garlicki J; Konturek PK; Majka J; Kwiecien N; Konturek SJ
Am J Physiol; 1990 Jan; 258(1 Pt 1):E40-5. PubMed ID: 2301570
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic endocrine dysfunction in rats not expressing the cholecystokinin-A receptor.
Funakoshi A; Miyasaka K; Kanai S; Masuda M; Yasunami Y; Nagai T; Ikeda S; Jimi A; Kawanami T; Kono A
Pancreas; 1996 Apr; 12(3):230-6. PubMed ID: 8830328
[TBL] [Abstract][Full Text] [Related]
30. Effect of CCK antagonist L 364718 on meal-induced pancreatic secretion in rats.
O'Rourke MF; Reidelberger RD; Solomon TE
Am J Physiol; 1990 Feb; 258(2 Pt 1):G179-84. PubMed ID: 1689547
[TBL] [Abstract][Full Text] [Related]
31. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
Boyle SJ; Tang KW; Woodruff GN; McKnight AT
Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent effects of CCK and devazepide in male and female rats.
Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
[TBL] [Abstract][Full Text] [Related]
33. Necessity of hyperglycemia for effects of endogenous cholecystokinin on insulin and pancreatic exocrine secretion in conscious rats.
Shikado F; Miyasaka K; Funakoshi A; Kitani K
Jpn J Physiol; 1990; 40(3):383-91. PubMed ID: 2273636
[TBL] [Abstract][Full Text] [Related]
34. Role of cholecystokinin in the anorexia produced by duodenal delivery of glucose in rats.
Woltman T; Reidelberger R
Am J Physiol; 1996 Dec; 271(6 Pt 2):R1521-8. PubMed ID: 8997348
[TBL] [Abstract][Full Text] [Related]
35. Role of cholecystokinin, gastrin and gastrin-releasing peptide in the regulation of pancreatic secretion in cats.
Konturek SJ; Bilski J; Hladij M; Krzyzek E; Cai RZ; Schally AV
Digestion; 1991; 49(2):97-105. PubMed ID: 1724767
[TBL] [Abstract][Full Text] [Related]
36. Cholecystokinin in the entero-insular axis.
Okabayashi Y; Otsuki M; Baba S
Diabetes Res Clin Pract; 1989; 7 Suppl 1():S79-85. PubMed ID: 2680370
[TBL] [Abstract][Full Text] [Related]
37. Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth.
Morisset J; Guan D; Jurkowska G; Rivard N; Green GM
Pancreas; 1992; 7(5):522-9. PubMed ID: 1381095
[TBL] [Abstract][Full Text] [Related]
38. Effects of CCK-8 on the cytoplasmic free calcium concentration in isolated rat islet cells.
Fridolf T; Karlsson S; Ahrén B
Biochem Biophys Res Commun; 1992 Apr; 184(2):878-82. PubMed ID: 1575756
[TBL] [Abstract][Full Text] [Related]
39. Pancreatic digestive enzyme gene expression: effects of CCK and soybean trypsin inhibitor.
Rosewicz S; Lewis LD; Wang XY; Liddle RA; Logsdon CD
Am J Physiol; 1989 Apr; 256(4 Pt 1):G733-8. PubMed ID: 2468294
[TBL] [Abstract][Full Text] [Related]
40. 2-Naphthalenesulphanyl-L-aspartyl-2-(phenethyl) amide (2-NAP) and food intake in rats: evidence that endogenous peripheral CCK does not play a major role as a satiety factor.
Ebenezer IS; Baldwin BA
Br J Pharmacol; 1995 Nov; 116(5):2371-4. PubMed ID: 8581271
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
